Detalhe da pesquisa
1.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
N Engl J Med
; 387(21): 1923-1934, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342113
2.
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.
Circulation
; 147(4): 284-295, 2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335517
3.
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
N Engl J Med
; 384(2): 117-128, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200892
4.
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
N Engl J Med
; 384(2): 129-139, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200891
5.
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial.
Am Heart J
; 269: 179-190, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38160917
6.
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial.
Diabetes Obes Metab
; 26(5): 1714-1722, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317618
7.
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
Eur Heart J
; 44(2): 129-138, 2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331326
8.
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.
Circulation
; 145(21): 1581-1591, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35510542
9.
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia.
N Engl J Med
; 382(16): 1520-1530, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32197277
10.
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
N Engl J Med
; 382(16): 1507-1519, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32187462
11.
Effect of inclisiran on lipids in primary prevention: the ORION-11 trial.
Eur Heart J
; 43(48): 5047-5057, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331315
12.
Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial.
Eur Heart J
; 43(31): 2958-2967, 2022 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34427295
13.
Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6.
Stroke
; 53(9): 2749-2757, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582947
14.
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
N Engl J Med
; 381(14): 1309-1320, 2019 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31475798
15.
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med
; 380(4): 347-357, 2019 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30415602
16.
Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI.
Am Heart J
; 249: 23-33, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35321823
17.
Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults.
Cardiovasc Diabetol
; 21(1): 104, 2022 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35689214
18.
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes.
Cardiovasc Diabetol
; 21(1): 158, 2022 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35996147
19.
Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease.
Diabetes Obes Metab
; 24(7): 1288-1299, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332654
20.
Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to iGlarLixi in the LixiLan ONE CAN randomized trial.
Diabetes Obes Metab
; 24(10): 1998-2007, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35670659